Radiomics and radiogenomics in neuro-oncology : an artificial intelligence paradigm. Volume 2, Genetics and clinical applications /
Provides readers with a broad and detailed framework for radiomics and radiogenomics (R-n-R) approaches with AI in neuro-oncology. It delves into the study of cancer biology and genomics, presenting methods and techniques for analyzing these elements. The book also highlights current solutions that...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
London, U.K. :
Academic Press,
[2025]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Section 1. Imaging signatures for brain cancer molecular characteristics. Chapter 1. Radiogenomics and genetic diversity of glioblastoma characterization
- Chapter 2. Machine and deep learning-based methods for genotype O(6)-methylguanine-DNA-methyltransferase status prediction
- Chapter 3. AI-based image signature for brain cancer molecular analysis
- Chapter 4. Imaging signatures for different mutation estimation for brain cancer
- Chapter 5. Software solutions for managing radiomics and radiogenomics in neuro-oncology clinical settings
- Section 2. Clinical applications of R-n-R in neuro-oncology. Chapter 6. Survival estimation of brain tumor patients using radiogenomics-based studies
- Chapter 7. Brain tumor progression analysis: a comprehensive review
- Chapter 8. Integrative data analysis of MGMT methylation and IDH1 mutation in glioblastoma: a comprehensive review
- Chapter 9. AI enabled R-n-R for neurooncology: clinical applications
- Section 3. AI in R-n-R for neuro-oncology: what have we achieved so far? Chapter 10. AI for application solutions for healthcare services using AI detection and diagnosis of different diseases: a special emphasis on neuro-oncology
- Chapter 11. Traditional and advanced AI methods used in the area of neuro-oncology
- Chapter 12. AI in radiomics and radiogenomics for neuro-oncology: achievements and challenges.